AQR CAPITAL MANAGEMENT LLC

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1167557 Greenwich, CT

Position in AGIO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$25,395,852

+$24,164,106 QoQ

Shares Held

684,340

+1779.5% QoQ

Ownership

1.15%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#24

of 238 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 98% Shared 0% None 2%

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. AGIO ranks #24 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,126,080	$702,155,918
2	INCY	Incyte Corp	5,320,901	$603,177,333
3	EXEL	Exelixis, Inc.	11,023,943	$599,812,735
4	JAZZ	Jazz Pharmaceuticals plc	1,522,568	$366,893,205
5	BMRN	Biomarin Pharmaceutical Inc	5,699,541	$326,127,732
6	VRTX	Vertex Pharmaceuticals Inc / Ma	616,170	$306,070,117
7	RVMD	Revolution Medicines, Inc.	1,295,450	$242,611,869
8	RPRX	Royalty Pharma plc	4,305,412	$241,404,446

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$25,395,852	684,340	+1779.5%	Shares	Other	2026-08-14
2026-03-31	$1,231,746	36,410	+30.4%	Shares	Other	2026-05-15
2025-12-31	$760,143	27,926	-69.5%	Shares	Other	2026-02-17
2025-09-30	$3,678,227	91,635	-5.4%	Shares	Other	2025-11-14
2025-06-30	$3,222,760	96,896	+88.2%	Shares	Other	2025-08-14
2025-03-31	$1,508,625	51,489	+66.8%	Shares	Other	2025-05-15
2024-12-31	$1,014,189	30,864	-77.7%	Shares	Defined	2025-02-14
2024-09-30	$6,137,648	138,142	+316.5%	Shares	Other	2024-11-14
2024-06-30	$1,430,031	33,164	+196.5%	Shares	Other	2024-08-14
2024-03-31	$327,019	11,184	+44.9%	Shares	Defined	2024-05-15
2023-06-30	$218,545	7,717	-77.7%	Shares	Defined	2023-08-14
2021-09-30	$1,593,605	34,531	+380.6%	Shares	Defined	2021-11-15
2021-06-30	$395,965	7,185	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.